Drug intelligence / Profile preview

First Defense

Development stage
Unknown
Lead developer
ImmuCell
Modality
Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

First Defense is a veterinary product designed to prevent neonatal calf scours (diarrhea) by providing passive immunity through orally administered antibodies. The product contains dried colostral antibodies derived from hyperimmune bovine colostrum, specifically targeting K99+ Escherichia coli and bovine coronavirus. When administered as a bolus or gel within the first 12 hours after birth, it delivers immediate protection by neutralizing these pathogens in the calf’s gastrointestinal tract. This approach bypasses the need for vaccination of either dam or calf and provides instant immunity against two of the most common causes of scours in newborn calves[1][7][10].

Brand names
First DefenseFirst Defense Bolus
Other names
Immucell First Defense Bolus
02

Targets

BCoV S (Bovine coronavirus spike protein)FanC (Major fimbrial subunit FanC)

Beyond the preview

Go deeper on First Defense.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on First Defense.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call